LensAR™ Laser System Receives FDA Clearance for Lens Fragmentation and Anterior Capsulotomy in Cataract Surgery
March 23, 2011
Submit Comments
LensAR, Inc., announced yesterday that the company has received 510(k) clearance from the FDA for use of the LensAR™ Laser System for anterior capsulotomy and lens fragmentation during cataract surgery.
The company’s CEO commented that “receiving the additional FDA indication for lens fragmentation is a significant milestone achievement in getting our technology one step closer to commercialization. We are very pleased with the exceptional fragmentation data that was submitted to obtain the indication and the resulting FDA clearance.”
Click here to read the full press release.
Comments
Jump down to form below to submit your own comments
